Clinical Trials in San Francisco

Showing 6221-6240 of 12,991 trials

Improving Mental Health and Well-Being Via Awe Walks

NCT03550144

Awe is a powerful positive emotion that offsets negative emotion and fosters prosocial behavior. This study examined the effects of awe on health and well-being in healthy older adults. Half of the participants took a weekly "awe walk" while the other half took a weekly walk with no further instructions.

AweCompassionAnxiety

University of California, San Francisco60 participantsStarted Dec 2016

San Francisco, California, United States

COMPLETEDNA< 1 mile

UCSF TARA Study: Training for Awareness, Resilience and Action

NCT02480257

The investigators aim to refine and pilot test an innovative group treatment model for adolescent depression and anxiety, Training for Awareness, Resilience and Action (TARA) in a sample of 14-18 year olds with depressive or anxious symptoms.

DepressionAnxiety

University of California, San Francisco26 participantsStarted Jan 2014

San Francisco, California, United States

COMPLETEDPhase 1< 1 mile

Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease

NCT03065192

Safety and efficacy of AADC gene transfer in participants with Parkinson's disease.

Idiopathic Parkinson's DiseaseParkinson's DiseaseBasal Ganglia Disease+6 more

Neurocrine Biosciences16 participantsStarted May 2017

San Francisco, California, United States • Atlanta, Georgia, United States • Columbus, Ohio, United States +1 more locations

Improving Mental Health and Well-Being Via Awe Walks

UCSF TARA Study: Training for Awareness, Resilience and Action

Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease

Find Trials by Condition in San Francisco

Primary Care eHealth Intervention for Improved Outcomes in Chronic Kidney Disease

Adaptive COVID-19 Treatment Trial 2 (ACTT-2)

Adaptive COVID-19 Treatment Trial (ACTT)

AURORA: A Study for the Efficacy and Safety of Cenicriviroc (CVC) for the Treatment of Liver Fibrosis in Adults With Nonalcoholic Steatohepatitis (NASH)

Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (Lisdexamfetamine Dimesylate) in Children Aged 6-12 Diagnosed With ADHD

A Phase 2 Clinical Study in Subjects With Primary Progressive Multiple Sclerosis to Assess the Efficacy, Safety and Tolerability of Two Oral Doses of Laquinimod Either of 0.6 mg/Day or 1.5mg/Day (Experimental Drug) as Compared to Placebo

A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults

Oral Immunotherapy for Desensitization in Children, Adolescents, and Young Adults With Hen Egg Allergy

The CIA Score: a Learner's Tool

Observational Study in Cystic Fibrosis Patients Using TOBI® PODHALER® or Other FDA Approved Inhaled Antipseudomonal Antibacterial Drugs

Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis

A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia

A Phase 2, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Belumosudil in Subjects With Moderate/Severe Chronic Plaque Psoriasis

A Study to Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants With Moderate to Severe Allergic Asthma

An Efficacy and Safety Study Of Pracinostat In Combination With Azacitidine In Adults With Acute Myeloid Leukemia

A Study of Opaganib in Coronavirus Disease 2019 Pneumonia

Blood Culture Improvement Guidelines and Diagnostic Stewardship for Antibiotic Reduction in Critically Ill Children